| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lite Strategy, Inc. | Director | Common Stock | 1.88K | $4.11K | $2.19 | Jul 15, 2025 | Direct |
| Renovacor, Inc. | Chief Financial Officer | Option | 155K | Mar 28, 2022 | Direct | ||
| Cellectar Biosciences, Inc. | Director | Stock option (right to buy) | 60K | Feb 14, 2025 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24.4K | Jan 2, 2025 | Direct | ||
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 20K | Jul 15, 2025 | Direct | ||
| Flexion Therapeutics Inc | Chief Financial Officer | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
| Flexion Therapeutics Inc | Chief Financial Officer | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MEIP | MEI Pharma, Inc. | Jul 15, 2025 | 1 | $0 | 4 | Jul 17, 2025 | Director |
| CLRB | Cellectar Biosciences, Inc. | Feb 14, 2025 | 1 | $0 | 4 | Feb 18, 2025 | Director |
| CUE | Cue Biopharma, Inc. | Jan 2, 2025 | 1 | $0 | 4 | Jan 3, 2025 | Director |
| CLRB | Cellectar Biosciences, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| CUE | Cue Biopharma, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| MEIP | MEI Pharma, Inc. | Sep 29, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Director |
| CLRB | Cellectar Biosciences, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 28, 2023 | Director |
| CUE | Cue Biopharma, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| IVVD | Invivyd, Inc. | Oct 13, 2022 | 0 | $0 | 3 | Oct 13, 2022 | Interim CFO |
| MEIP | MEI Pharma, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 7, 2022 | Director |
| CLRB | Cellectar Biosciences, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Aug 1, 2022 | Director |
| RCOR | Renovacor, Inc. | Mar 28, 2022 | 1 | $0 | 4 | Mar 28, 2022 | Chief Financial Officer |
| RCOR | Renovacor, Inc. | Mar 28, 2022 | 0 | $0 | 3 | Mar 28, 2022 | Chief Financial Officer |
| CUE | Cue Biopharma, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 2 | -$261K | 4 | Nov 19, 2021 | Chief Financial Officer |
| CLRB | Cellectar Biosciences, Inc. | Sep 3, 2021 | 1 | $20.2K | 4 | Sep 7, 2021 | Director |
| MEIP | MEI Pharma, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director |
| CLRB | Cellectar Biosciences, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
| FLXN | Flexion Therapeutics Inc | Jun 1, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Chief Financial Officer |
| FLXN | Flexion Therapeutics Inc | Jun 1, 2021 | 0 | $0 | 3 | Jun 3, 2021 | Chief Financial Officer |